Laboratories face a series of upcoming deadlines to comply with stricter FDA oversight of in-house tests. Here are five ...

You may have heard about — or maybe even experienced — the short-term side effects of Ozempic® — such as nausea, vomiting, ...

The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.

The label also alerts patients that the drug is associated with urinary retention ... as well as to understand and potentially guide doctors on how to adjust doses for patients as their symptoms ...

While the regulator has not approved their use in type 1 diabetes, off-label prescribing for GLP-1 receptor agonists has ...

Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...

UCB submitted a supplemental biologics license application for bimekuzimab (Bimzelyx) to the FDA in April for the drug’s approval in moderate to severe hidradenitis suppurativa (HS).

Postmarketing requirement fulfilled based on data demonstrating QYSMIA® reduces blood pressure -CAMPBELL, Calif., Oct. 28, 2024 (GLOBE ...

National Drug Take Back Day is Thursday, but Maryland residents don't have to wait - the state has a variety of options for ...

WuXi XDC uses the label innovation that combines light protection and blinding of the drug. The light protection label from ...

At this time, I would like to welcome everyone to Harmony Biosciences Third Quarter 2024 Financial Results Conference Call. All participants have been placed on mute to prevent any background noise.